PharmaEssentia Corporation (TPE:6446)

PharmaEssentia Revenue

PharmaEssentia had revenue of 6.86B TWD in the quarter ending June 30, 2026, with 90.30% growth. This brings the company's total for the last twelve months to 20.75B, up 64.25% year-over-year. In the year 2025, PharmaEssentia had annual revenue of 15.63B with 60.61% growth. That makes PharmaEssentia the 9,865th largest company in the world by revenue and 276th in Taiwan.

• Revenue (ttm): 20.75B
• Revenue Growth: +64.25%
• P/S Ratio: 23.17
• Revenue / Employee: 158.41M
• Employees: 131
• Market Cap: 480.74B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Revenue from Sale of Medicine Products 15.55B 99.5%
• Revenue from Royalty Income 52.91M 0.3%
• Revenue Arising from Rendering of Services 31.26M 0.2%

By Geography

Chart

• America 11.97B 76.6%
• Europe 1.87B 11.9%
• Asia (excluding Taiwan) 1.40B 9.0%
• Taiwan 395.12M 2.5%

Fiscal year ended Dec 31, 2025 See the full PharmaEssentia breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.63B	5.90B	60.61%
Dec 31, 2024	9.73B	4.63B	90.67%
Dec 31, 2023	5.11B	2.22B	77.15%
Dec 31, 2022	2.88B	2.23B	339.00%
Dec 31, 2021	656.51M	99.25M	17.81%

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error